Treating Hydrocephalus with Retrograde Ventriculosinus Shunt: Prospective Clinical Study

Area of Science:

• Neurosurgery
• Biomedical Engineering

Background:

• Traditional cerebrospinal fluid (CSF) shunts for hydrocephalus treatment, often directed to the peritoneal cavity or right atrium, cause nonphysiologic drainage and high revision rates.
• Advanced shunt valves increase costs and complexity, yet remain ineffective for some patients.
• Ventriculosinus shunts, directing CSF to dural sinuses, leverage natural antisiphoning effects but have not achieved standard practice.

Purpose of the Study:

• To evaluate the feasibility and long-term outcomes of retrograde ventriculosinus shunts.
• To identify reasons for shunt failure and propose solutions for improved clinical application.

Main Methods:

• A single-center prospective study involving the implantation of retrograde ventriculosinus shunts in 10 hydrocephalus patients.
• Detailed reporting of surgical technique, long-term outcomes, and analysis of shunt functionality, including 4 rescue operations.

Main Results:

• Ventriculosinus shunt implantation was feasible, enabling physiologic CSF drainage.
• Only 3 of 14 patients maintained shunt functionality for over 6 years.
• Frequent shunt obstruction was linked to difficulties in implanting current venous access devices.

Conclusions:

• Current retrograde ventriculosinus shunts demonstrate limited long-term functionality, primarily due to device-related issues.
• A novel, easily implantable, and thrombogenic-resistant dural venous sinus access device is required for ventriculosinus shunting to become a standard neurosurgical procedure.